{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:43:38Z","timestamp":1789393418682,"version":"build-2803163510"},"reference-count":30,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2022,3,4]]},"DOI":"10.1080\/1744666x.2022.2038134","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T09:16:09Z","timestamp":1644830169000},"page":"273-280","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":21,"title":["Tofacitinib for the treatment of active ankylosing spondylitis in adults"],"prefix":"10.1080","volume":"18","author":[{"given":"Raagav","family":"Mohanakrishnan","sequence":"first","affiliation":[{"name":"Division of Arthritis & Rheumatic Diseases, Oregon Health & Science University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Secia","family":"Beier","sequence":"additional","affiliation":[{"name":"Division of Arthritis & Rheumatic Diseases, Oregon Health & Science University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Deodhar","sequence":"additional","affiliation":[{"name":"Division of Arthritis & Rheumatic Diseases, Oregon Health & Science University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60071-8"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.13"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24025"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01001-1"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6248"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2017.04.006"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2012.08.018"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-014-0489-6"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1002\/art.39282"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.3402\/mehd.v26.26191"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1249-5"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftw111"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.10.003"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206323"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.591176"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key070"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4447"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0701-9"},{"key":"cit0019","volume-title":"Xeljanz (Tofacitinib)","author":"Labs P","year":"2018"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210322"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key104"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-219601"},{"key":"cit0023","unstructured":"Adapted from \u201cFullTemplateName\u201d, by BioRender.com (CurrentYear). Available from: https:\/\/app.biorender.com\/biorender-templates."},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-04970-3"},{"key":"cit0025","unstructured":"Inc P. Pfizer shares co-primary endpoint results from post-marketing required safety study of xeljanz\u00ae (Tofacitinib) in subjects with rheumatoid arthritis (RA), in ORAL surveillance study results; 2021."},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32463-2"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32534-6"},{"key":"cit0028","unstructured":"FDA. FDA drug safety communication, in FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions; 2021."},{"issue":"9","key":"cit0029","first-page":"572","volume":"12","author":"Feagan B","year":"2016","journal-title":"Gastroenterol Hepatol"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz186"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2022.2038134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T12:05:16Z","timestamp":1649246716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2022.2038134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,4]]}},"alternative-id":["10.1080\/1744666X.2022.2038134"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2022.2038134","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-08-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}